Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria

NCT05750459 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Infection

Interventions

DRUG: Artesunate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)